Clinical Trials Browser

Approved for marketing × Bites and Stings × Clear all

NCT06064500 2025-03-10

Tarlatamab (AMG 757) Expanded Access Protocol for Advanced Small Cell Lung Cancer

Approved for marketing

Bites and Stings, Lung Neoplasms, Small Cell Lung Carcinoma